Peter F Zipfel Selected Research

Complement Factor H Deficiency

2/2009	Factor I and factor H deficiency in renal diseases: similar defects in the fluid phase have a different outcome at the surface of the glomerular basement membrane.
1/2007	MPGN II--genetically determined by defective complement regulation?
2/2005	Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter F Zipfel Research Topics

Disease

28	Hemolytic-Uremic Syndrome 01/2018 - 02/2001
24	Infections 01/2024 - 06/2002
20	Atypical Hemolytic Uremic Syndrome 01/2023 - 02/2005
19	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 01/2006
19	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 12/2002
16	Inflammation (Inflammations) 01/2023 - 02/2003
10	Kidney Diseases (Kidney Disease) 01/2023 - 09/2007
10	Lyme Disease (Disease, Lyme) 01/2014 - 04/2004
8	Hemolysis 01/2022 - 02/2007
7	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2008
6	Proteinuria 02/2023 - 09/2007
6	Thrombosis (Thrombus) 11/2021 - 04/2003
6	Thrombotic Microangiopathies 08/2021 - 02/2005
6	Glomerulonephritis 08/2021 - 01/2013
5	Chronic Kidney Failure (Chronic Renal Failure) 08/2018 - 02/2008
4	Thrombocytopenia (Thrombopenia) 02/2024 - 02/2007
4	IGA Glomerulonephritis (IGA Nephropathy) 01/2023 - 01/2019
4	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2023 - 01/2019
4	Disease Progression 12/2021 - 09/2006
4	Malaria 01/2021 - 01/2013
4	Blindness (Hysterical Blindness) 10/2011 - 07/2007
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 11/2014
3	Vasculitis (Vasculitides) 01/2023 - 01/2019
3	Necrosis 11/2021 - 07/2005
3	Neoplasms (Cancer) 01/2020 - 07/2011
3	Candidiasis (Moniliasis) 01/2019 - 04/2012
3	Relapsing Fever 01/2017 - 06/2007
3	Renal Insufficiency (Renal Failure) 08/2009 - 05/2005
3	Complement Factor H Deficiency 02/2009 - 02/2005
2	COVID-19 02/2024 - 01/2023
2	Mycoses (Diseases, Fungus) 11/2023 - 01/2021
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 10/2022 - 01/2013
2	Retinal Diseases 01/2020 - 12/2008
2	Soft Tissue Infections 01/2019 - 12/2003
2	Sepsis (Septicemia) 01/2019 - 01/2009
2	Eye Diseases (Eye Disease) 01/2019 - 01/2006
2	Hypertension (High Blood Pressure) 01/2016 - 02/2008
2	Hypersensitivity (Allergy) 01/2016 - 05/2014
2	Rheumatic Diseases (Rheumatism) 01/2014 - 08/2012
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2012 - 09/2009
2	Thrombocytopenic Purpura (Thrombopenic Purpura) 11/2011 - 07/2010
2	Thrombotic Thrombocytopenic Purpura 09/2009 - 11/2003
2	Immune System Diseases (Immune Disorders) 12/2008 - 01/2006
2	Communicable Diseases (Infectious Diseases) 08/2008 - 09/2007
2	Rare Diseases (Rare Disease) 09/2007 - 01/2007
2	Intestinal Volvulus (Volvulus) 04/2003 - 06/2002
1	Influenza in Birds (Avian Flu) 01/2024
1	Ascites 01/2023
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Neuroblastoma 01/2022

Drug/Important Bio-Agent (IBA)

89	Complement System Proteins (Complement)IBA 01/2024 - 06/2002
61	Complement Factor H (Factor H)IBA 01/2024 - 02/2001
34	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2002
13	AutoantibodiesIBA 01/2021 - 09/2007
7	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019 - 09/2007
7	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 04/2005
6	Complement Inactivating AgentsIBA 01/2023 - 08/2009
6	eculizumab FDA Link 10/2022 - 09/2007
4	Heparin (Liquaemin)FDA LinkGeneric 02/2024 - 04/2003
4	AntibodiesIBA 02/2024 - 04/2003
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 05/2009
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023 - 01/2019
4	Fibrinolysin FDA Link 01/2021 - 01/2009
4	PlasminogenIBA 01/2021 - 06/2007
4	thiamine triphosphorate (TTP)IBA 11/2011 - 02/2001
4	Fibrinogen (Factor I)FDA Link 01/2010 - 09/2006
3	Immunoglobulin G (IgG)IBA 01/2023 - 04/2003
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022 - 08/2009
3	ProperdinIBA 01/2022 - 01/2013
3	Blood Proteins (Serum Proteins)IBA 01/2017 - 09/2010
3	LigandsIBA 01/2016 - 05/2005
2	Platelet Factor 4IBA 02/2024 - 10/2022
2	CreatinineIBA 02/2023 - 01/2018
2	AntigensIBA 01/2023 - 06/2002
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2009
2	Peptides (Polypeptides)IBA 12/2021 - 02/2003
2	ApolipoproteinsIBA 11/2021 - 01/2019
2	LipidsIBA 11/2021 - 01/2017
2	Monoclonal AntibodiesIBA 01/2020 - 05/2005
2	Apolipoproteins E (ApoE)IBA 03/2019 - 01/2019
2	Complement C3b (C3bi)IBA 01/2016 - 06/2002
2	Complement Receptors (Complement Receptor)IBA 01/2016 - 01/2016
2	Retinal Pigments (Pigments, Visual)IBA 10/2015 - 01/2010
2	Messenger RNA (mRNA)IBA 11/2014 - 07/2011
2	Virulence Factors (Pathogenicity Factors)IBA 03/2014 - 06/2007
2	human CFH proteinIBA 01/2013 - 12/2002
2	CytokinesIBA 04/2012 - 07/2005
2	Complement Factor B (Factor B)IBA 12/2011 - 01/2010
2	VaccinesIBA 09/2007 - 04/2003
2	Membrane Cofactor ProteinIBA 03/2007 - 09/2006
2	A-factor (Streptomyces)IBA 02/2007 - 02/2005
1	Immunoglobulin M (IgM)IBA 01/2023
1	nephrinIBA 01/2023
1	polysialic acidIBA 01/2022
1	factor H-related protein 1IBA 11/2021
1	NeopterinIBA 11/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2021

Therapy/Procedure

8	Therapeutics 01/2023 - 02/2005
2	Kidney Transplantation 01/2022 - 08/2018
2	Transplantation 01/2016 - 10/2010